Items where Subject is "Australian and New Zealand Standard Research Classification > MEDICAL AND HEALTH SCIENCES (110000) > ONCOLOGY AND CARCINOGENESIS (111200) > Molecular Targets (111207)"
 | Up a level |
- Subjects classification (32824)
- Australian and New Zealand Standard Research Classification (32824)
- MEDICAL AND HEALTH SCIENCES (110000) (6766)
- ONCOLOGY AND CARCINOGENESIS (111200) (348)
- Molecular Targets (111207) (8)
- ONCOLOGY AND CARCINOGENESIS (111200) (348)
- MEDICAL AND HEALTH SCIENCES (110000) (6766)
- Australian and New Zealand Standard Research Classification (32824)
Group by: Authors/Creators | Item Type
Jump to: Book Chapter | Journal Article
Number of items at this level: 8.
Book Chapter
Jingjing, You, Cozzi, Paul, Fitzgerald , Anna, Walsh, Bradley, Russell, Pamela J., Willcox, Mark, et al. (2012) Prostate cancer biomarkers and the emerging proteomic techniques used in biomarker research. In Watanabe, Hiroto S. (Ed.) Horizons in Cancer Research : Volume 47. Nova Science Publishers Inc, New York, pp. 1-36.
Journal Article
Byron, Sara A., Gartside, Michael, Powell, Matthew A., Wellens, Candice L., Gao, Feng, Mutch, David G., et al. (2012) FGFR2 point mutations in 466 Endometrioid Endometrial Tumors : relationship with MSI, KRAS, PIK3CA, CTNNB1 mutations and Clinicopathological features. PLoS ONE, 7(2), e30801-e30801.
29 
6 
6
29 6 6Byron, Sara A., Loch, David, & Pollock, Pamela M. (2012) Fibroblast growth factor receptor inhibition synergizes with paclitaxel and doxorubicin in endometrial cancer cells. International Journal of Gynecological Cancer, 22(9), pp. 1517-1526.
1
1Byron, Sara A., Loch, David C., Wellens, Candice L., Wortmann, Andreas, Wu, Jiayi, Wang, John, et al. (2012) Sensitivity to the MEK inhibitor E6201 in melanoma cells is associated with mutant BRAF and wildtype PTEN status. BMC Molecular Cancer, 11(75).
25
25Chopin, L. K., Seim, I., Walpole, C. M., & Herington, A. C. (2012) The Ghrelin axis : does it have an appetite for cancer progression? Endocrine Reviews, 33(6), pp. 849-891. (In Press)
1
1Loch, David & Pollock, Pamela M. (2012) Lineage-specific biomarkers predict response to FGFR inhibition. Cancer Discovery, 2, pp. 1081-1083.
Rutowski, Raphael, Mertens-Walker, Inga, Lisle, Jessica E, Herington, Adrian C., & Stephenson, Sally-Anne (2012) Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand. International Journal of Cancer, 131(5), E614-E624.
2 2
2 2Wang, Qian, Tiffen, Jessamy, Bailey, Charles G., Lehman, Melanie, Ritchie, William, Fazli, Ladan, et al. (2013) Targeting amino acid transport in metastatic castration-resistant prostate cancer suppresses cell cycle, cell growth and tumor development. .
53
53